ID

22565

Descrizione

Study ID: 100310 Clinical Study ID: RRL100310 Study Title: A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of intermittent dosing of ropinirole in patients with Restless Legs Syndrome (RLS) Part 15: Visit 3 (Week 5) RLS Episode 3 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00225862 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome More details on: https://clinicaltrials.gov/ct2/show/NCT00225862

collegamento

https://clinicaltrials.gov/ct2/show/NCT00225862

Keywords

versioni (2)
  1. 08.06.17 08.06.17 -
  2. 12.06.17 12.06.17 -
Caricato su

8. Juni 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 15: Visit 3 (Week 5) RLS Episode 3

Inglese

Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 15: Visit 3 (Week 5) RLS Episode 3

1 moduli  
General Information
Descrizione

General Information

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

text

PRN Subject Diary
Descrizione

PRN Subject Diary

1. Enter the date and time your RLs symptoms started.
Descrizione

Date

Tipo di dati

datetime

2. How severe were your RLS symptoms at the time you took the dose of study medication?
Descrizione

Severity of RLS episode

Tipo di dati

text

3. Did your RLS symptoms disrupt your routine evening activity?
Descrizione

Did your RLS symptoms disrupt your routine evening activity?

Tipo di dati

boolean

4. How severe were your RLS symptoms 2 hours after taking the study medication?
Descrizione

Severity two hours after medication

Tipo di dati

text

5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
Descrizione

Read the following and complete the questions when you wake up next morning.

Tipo di dati

text

6. Overall, did your RLS symptoms affect your sleep last night?
Descrizione

Sleep affected by RLS symptoms?

Tipo di dati

boolean

If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
Descrizione

Specification of RLS symptoms affecting sleep

Tipo di dati

boolean

Study Medication
Descrizione

Study Medication

Date study medication taken
Descrizione

Date study medication taken

Tipo di dati

date

Time study medication taken
Descrizione

Time study medication taken

Tipo di dati

time

Ritorna all'inizio della pagina

Similar models

Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 15: Visit 3 (Week 5) RLS Episode 3

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
General Information
Subject Identifier
Item
Subject Identifier
text
Item Group
PRN Subject Diary
Date
Item
1. Enter the date and time your RLs symptoms started.
datetime
Item
2. How severe were your RLS symptoms at the time you took the dose of study medication?
text
Severity of RLS episode
Code List
2. How severe were your RLS symptoms at the time you took the dose of study medication?
CL Item
mild (1)
CL Item
moderate (2)
CL Item
severe (3)
CL Item
very severe (4)
Did your RLS symptoms disrupt your routine evening activity?
Item
3. Did your RLS symptoms disrupt your routine evening activity?
boolean
Item
4. How severe were your RLS symptoms 2 hours after taking the study medication?
text
Severity two hours after medication
Code List
4. How severe were your RLS symptoms 2 hours after taking the study medication?
CL Item
I was asleep at 2 hours after taking the last dose  (1)
CL Item
None (2)
CL Item
Mild (3)
CL Item
Moderate (4)
CL Item
Severe (5)
CL Item
Very Severe (6)
Item
5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
text
Change in RLS symptoms after dosing the night before
Code List
5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
CL Item
Very much improved (Complete symptom relief) (1)
CL Item
Much improved (Good symptom relief) (2)
CL Item
Minimally improved (Some symptom relief) (3)
CL Item
No change (4)
CL Item
Minimally worse (Symptoms minimally worse) (5)
CL Item
Much worse (Symptoms much worse) (6)
CL Item
Very much worse (Symptoms very much worse) (7)
Sleep affected by RLS symptoms?
Item
6. Overall, did your RLS symptoms affect your sleep last night?
boolean
Specification of RLS symptoms affecting sleep
Item
If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
boolean
Item Group
Study Medication
Date study medication taken
Item
Date study medication taken
date
Time study medication taken
Item
Time study medication taken
time
Ritorna all'inizio della pagina 

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial